Related Experiment Video
Updated: Jun 12, 2026
07:13
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Ameloblastic carcinoma: a multicenter Nigerian study.
Kizito C Ndukwe1, Emmanuel K Adebiyi, Vincent I Ugboko
1Faculty of Dentistry, Obafemi Awolowo University, Ile-Ife, Nigeria. kizitondukwe@yahoo.com
Summary
Ameloblastic carcinoma is a rare cancer, often starting in the jawbone. Early detection and surgical removal are key to successful treatment in Nigerian patients.
Area of Science:
- Oral and Maxillofacial Pathology
- Surgical Oncology
- Head and Neck Cancer Research
Background:
- Ameloblastic carcinoma is a rare odontogenic malignancy.
- Understanding its prevalence and management is crucial for improving patient outcomes.
Purpose of the Study:
- To establish a national profile for ameloblastic carcinoma in Nigeria.
- To analyze the prevalence and management strategies for this rare cancer.
Main Methods:
- Retrospective analysis of case files from four Nigerian tertiary referral centers (1980-2008).
- Inclusion criteria: histologic diagnosis of ameloblastic carcinoma.
- Data collected on patient demographics, lesion characteristics, treatment, and outcomes.
Main Results:
- Twenty cases of ameloblastic carcinoma were identified.
- The majority of cases (17/20) occurred de novo, with a predilection for the mandible.
- Treatment involved surgical resection; however, 8 patients declined treatment, and 6 deaths were recorded.
Conclusions:
- Ameloblastic carcinoma is an uncommon malignancy in Nigeria, predominantly affecting the mandible and arising de novo.
- Early diagnosis and radical surgical excision are critical for effective management.
- Further research into optimal treatment protocols is warranted.